Autoimmune Neurology in the Diagnostic Laboratory
Alzheimer’s Disease: The Role of Amyloid Beta 42/40 in Risk Assessment
Give Us Your Feedback
Date: Tuesday, June 16, 2015
Author: Waldman, Frederic, MD, PhD
Medical Director, Cancer Diagnostics
Quest Diagnostics Nichols Institute
San Juan Capistrano, CA
Also by this Author ▸
Description: Frederic Waldman, MD, PhD, Quest Diagnostics medical director for cancer diagnostics discusses the role of personalized medicine in improving cancer diagnostics.
Genetics and Genomics in Clinical Medicine: Perspectives In Personalized Medicine
Kucherlapati, Raju, PhD
Monitoring of Myeloid Neoplasms in the Era of Next Generation Sequencing
Racke, Frederick K., MD, PhD.
BRCAvantage™: An In-depth Discussion
Waldman, Frederic, MD, PhD